Defective IgG Class Switching in the Spleen of TRAF5-Deficient Mice Reveals a Role for TRAF5 in CD40-Mediated B Cell Responses During Obesity-Associated Inflammation
International Journal of Molecular Sciences · 28.09.2025 · 26 (19) · 9494
DOI: 10.3390/ijms26199494 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.09.2025. Verfasst von Tomomi Wakaizumi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Cell Biology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, …. Hauptthemen laut MEDLINE: Obesity, B-Lymphocytes, Spleen, Immunoglobulin Class Switching. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Tumor necrosis factor receptor-associated factors (TRAFs) are a family of adaptor proteins that transmit signals from immunoregulatory receptors—such as TNF receptors, Toll-like receptors, and interleukin receptors—to coordinate immune and inflammatory responses. Among them, TRAF5 is highly expressed in lymphocytes and implicated in obesity-associated inflammation, but its role in secondary lymphoid organs during chronic low-grade inflammation remains unclear. We examined splenic B and T cell phenotypes in wild-type (WT) and Traf5-deficient (KO) mice fed a high-fat diet (HFD). Although lymphocyte composition was broadly comparable, KO mice showed reduced spontaneous immunoglobulin G2c (IgG2c) production ex vivo—about 1.5-fold lower than WT. Notably, despite elevated TNF-α and CD40 ligand (CD40L) expression in HFD-fed KO splenocytes, IgG2c production remained diminished—about 1.9-fold lower than WT—upon soluble CD40L stimulation, indicating impaired CD40-mediated class-switch recombination (CSR). Consistently, B cells from KO mice on a normal diet exhibited reduced activation-induced cytidine deaminase (AID) expression—about 4.4-fold lower than WT—after CD40L stimulation, and decreased IgG2c secretion—about 6.6-fold lower—upon CD40L and IFN-γ co-stimulation in vitro. Collectively, these findings suggest that TRAF5 is involved in CD40-dependent CSR in B cells under inflammatory conditions and may contribute to sustaining adaptive immune responses during obesity-associated chronic inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Cell Biology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
- Department of Clinical Pharmacology, University of Toyama, Toyama 930-0194, Japan.
ORCID-Profile: Mari Hikosaka-Kuniishi, Tsutomu Wada, Toshiyasu Sasaoka, Takanori So
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Wakaizumi, T., Hikosaka-Kuniishi, M., Ozawa, Y., Sato, A., Iwata, C., Wada, T., Sasaoka, T., Morita, M., & So, T. (2025). Defective IgG Class Switching in the Spleen of TRAF5-Deficient Mice Reveals a Role for TRAF5 in CD40-Mediated B Cell Responses During Obesity-Associated Inflammation. International Journal of Molecular Sciences, 26(19), 9494. https://doi.org/10.3390/ijms26199494
Vancouver
Wakaizumi T, Hikosaka-Kuniishi M, Ozawa Y, Sato A, Iwata C, Wada T, et al. Defective IgG Class Switching in the Spleen of TRAF5-Deficient Mice Reveals a Role for TRAF5 in CD40-Mediated B Cell Responses During Obesity-Associated Inflammation. International Journal of Molecular Sciences. 2025;26(19):9494. doi:10.3390/ijms26199494
BibTeX
@article{Wakaizumi2025,
author = {Wakaizumi, Tomomi and Hikosaka-Kuniishi, Mari and Ozawa, Yusuke and Sato, Ayaka and Iwata, Chieri and Wada, Tsutomu and Sasaoka, Toshiyasu and Morita, Masashi and So, Takanori},
title = {Defective IgG Class Switching in the Spleen of TRAF5-Deficient Mice Reveals a Role for TRAF5 in CD40-Mediated B Cell Responses During Obesity-Associated Inflammation},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {19},
pages = {9494},
doi = {10.3390/ijms26199494}
}
EUVIMED